Wound Management Technologies has signed a letter of intent to acquire US-based medical device distributor Juventas.
Juventas products are used in surgical and non-surgical therapy, as well as in regenerative medicine.
Go deeper with GlobalData
As part of the agreement, Juventas principals Jeff Ott and Bryant Gaines will provide management services to Wound Management Technologies.
Gaines said the Juventas is currently evaluating additional core products to add to its portfolio for 2012, along with ancillary products to complement the existing products.
The acquisition includes an all-stock deal that will result in the owners of Juventas obtaining 12.5 million shares of Wound Management Technologies.
The transaction is subject to a number of conditions, and is expected to close by the first quarter of 2012.
